For the second consecutive year, Seattle-based Hagens Berman Sobol Shapiro (HBSS) earned a spot on the National Law Journal's (NLJ) prestigious "Plaintiff's Hot List," an award given the top 12 plaintiff law firms in the country that demonstrate impressive verdicts and settlements, and those firms taking on cases of significant public importance.

Among the cases cited by the NLJ was HBSS's work in holding the pharmaceutical industry accountable for allegedly inflating the price of many brand name drugs. HBSS has recovered more than $100 million in settlements and verdicts with some of the named defendants including AstraZeneca, Bristol Myers-Squibb and GlaxoSmithKline. More - and potentially larger - verdicts are expected in related cases.

"I am very happy that the National Law Journal recognizes the importance of the work our team is doing at HBSS," said managing partner Steve Berman. "The fact that we've been included in the list two years running is a testament to the enduring hard work of a very talented group of men and women in our six offices across the country."

The firm was also lauded for its work in a similar case involving FirstDatabank, a case that has saved consumers an estimated $4 billion in prescription costs as part of a settlement reached in June of 2007.

The NLJ also cited HBSS's work in the Serono International case, a settlement involving the off-label marketing of the AIDS drug Serostim, and a settlement that addressed the United States' role in withholding property of Jewish Holocaust victims seized by the Nazis at end of World War II.

The National Law Journal publishes its Plaintiffs' Hot List annually and has for the past six years. This year's list appeared on Oct. 22 and can be found on NLJ's Web site at http://www.law.com/jsp/nlj/.